Meredith Jones~~Étienne Renaudeau
January 24, 2026
KKR to Invest in Darktrace

1 min
AI-made summary
- Simpson Thacher is advising KKR on its investment in Darktrace Limited, a cybersecurity technology company based in Cambridge, England
- Darktrace's Enterprise Immune System is used by major organizations across various sectors
- In this funding round led by KKR, Darktrace will raise approximately $65 million from KKR and other investors
- The transaction is expected to close in mid-July 2016
- The advisory team includes specialists in M&A, tax, and antitrust.
The Firm is representing KKR in connection with its investment in Darktrace Limited, a cyber security technology company headquartered in Cambridge, England. Darktrace's Enterprise Immune System has been selected by some of the largest and most sensitive cyber security environments, including global financial institutions, telecommunications networks, legal firms, retailers, technology companies, government organizations and critical national infrastructure facilities.~~As part of this latest funding round which is being led by KKR, Darktrace will raise approximately $65 million from KKR and other investors. The transaction is expected to complete in mid-July 2016.~~The Simpson Thacher team advising KKR includes Neil Evans and Patrick Scott (M&A); Meredith Jones (Tax); and David Vann, Etienne Renaudeau and Tara Kelly (Antitrust).
Article Author
Meredith Jones~~Étienne Renaudeau
The Sponsor
